- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Moderate to Severe Chronic Kidney Disease
Total 5279 results
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-Type PsoriasisUnited States, Germany, Japan, Bulgaria, Czechia, Singapore, Switzerland, United Kingdom, Italy, France, Vietnam, Poland, Slovakia, Austria, Canada
-
Sun Pharmaceutical Industries LimitedActive, not recruitingChronic Plaque Psoriasis | Moderate to Severe Nail PsoriasisUnited States, Australia
-
UCB Biopharma SRLCompletedModerate to Severe Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, Taiwan
-
PfizerCompleted
-
QRxPharma Inc.CompletedAcute Moderate to Severe PainUnited States
-
Merz North America, Inc.CompletedCorrection of Moderate to Severe Nasolabial FoldsUnited States
-
AbbVie (prior sponsor, Abbott)WithdrawnModerate to Severe Chronic Plaque Psoriasis
-
Janssen PharmaceuticaWithdrawnModerate to Severe Acute Non-Cancer Pain
-
BioPharmX, Inc.CompletedModerate to Severe Papulopustular RosaceaUnited States
-
Merck Sharp & Dohme LLCTerminatedWomen | Moderate to Severe Vasomotor Symptoms in Postmenopausal
-
KoBioLabsNovotech (Australia) Pty LimitedCompletedModerate to Severe AsthmaAustralia
-
Galderma R&DCompletedChronic Kidney Disease Associated Moderate to Severe PruritusSpain, United States, Hungary, Poland
-
Egalet LtdCompletedModerate-to-severe Chronic Low Back PainUnited States
-
DiaMedica Therapeutics IncCompletedDiabetes | Chronic Kidney Disease | Chronic Kidney Disease, Stage 4 (Severe) | Chronic Kidney Disease, Stage 3 (Moderate)United States
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-type PsoriasisBelgium, Spain, Russian Federation, Germany, United States, Czechia, Peru, Poland, Estonia
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-type PsoriasisUnited States, Hungary, Italy, Russian Federation, Germany, Czechia, Canada
-
Actavis Inc.CompletedModerate to Severe Papulopustular RosaceaUnited States
-
Shanghai Junshi Bioscience Co., Ltd.CompletedModerate to Severe PsoriasisChina
-
Bristol-Myers SquibbTerminatedPsoriasis, Moderate to SevereUnited States
-
Wake Forest University Health SciencesCompleted
-
Merck KGaA, Darmstadt, GermanyCompletedModerate to Severe PsoriasisSwitzerland
-
Merck KGaA, Darmstadt, GermanyCompletedModerate to Severe PsoriasisSwitzerland
-
PfizerCompletedModerate to Severe PsoriasisKorea, Republic of
-
Chang Gung Memorial HospitalCompletedModerate to Severe COPD Receiving Home Exercise TrainingTaiwan
-
AstraZenecaCompletedModerate to Severe COPDSweden, Bulgaria, Poland, Denmark, Slovakia
-
GC Cell CorporationRecruitingClinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With PsoriasisModerate to Severe Plaque PsoriasisKorea, Republic of
-
UCB Biopharma SRLActive, not recruitingModerate to Severe Plaque PsoriasisUnited States, Canada, Germany, Poland
-
TakedaNimbus Lakshmi, Inc.; Innovaderm Research Inc.CompletedModerate to Severe Plaque PsoriasisUnited States, Canada
-
BiocadCompleted
-
AbbVieCompleted
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Plaque PsoriasisRussian Federation
-
Kyowa Kirin Co., Ltd.Completed
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPD | Moderate to Very Severe COPDUnited States, Canada
-
Chiesi Farmaceutici S.p.A.CompletedModerate to Severe Chronic Obstructive Pulmonary Disease (COPD)Bulgaria, Germany, Hungary, Poland, Russian Federation, United Kingdom
-
UCB Biopharma SRLRecruiting
-
Bristol-Myers SquibbNot yet recruitingModerate-to-severe Plaque PsoriasisKorea, Republic of
-
Novartis PharmaceuticalsRecruitingModerate-to-severe Plaque PsoriasisRussian Federation
-
Kyowa Kirin Korea Co., Ltd.CompletedModerate to Severe Plaque PsoriasisKorea, Republic of
-
UCB Biopharma SRLCompletedModerate to Severe Plaque PsoriasisKorea, Republic of
-
Novartis PharmaceuticalsCompletedModerate-to-severe Plaque PsoriasisIndonesia
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Plaque PsoriasisGermany
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...UnknownModerate to Severe Plaque PsoriasisChina
-
Bausch Health Americas, Inc.TerminatedModerate to Severe Plaque PsoriasisUnited States, Austria, France, Poland, Australia, Czechia, Canada, Hungary, Portugal, Spain, Netherlands
-
Jiangsu HengRui Medicine Co., Ltd.UnknownModerate-to-severe Plaque PsoriasisChina
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Plaque PsoriasisCzech Republic, Estonia, Hungary, Israel, Romania, Slovakia, Slovenia, Ukraine
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Plaque PsoriasisUnited States, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Italy, Spain, Sweden, Switzerland, United Kingdom
-
AbbottWithdrawnModerate to Severe Plaque Psoriasis
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.RecruitingModerate-to-Severe Plaque PsoriasisChina
-
Beijing InnoCare Pharma Tech Co., Ltd.RecruitingModerate to Severe Plaque PsoriasisChina
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingModerate-to-Severe Plaque Psoriasis